Insulin Resistance Intervention After Stroke Trial "IRIS"

Completed

Phase 3 Results

Summary of Purpose

The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 January 2016.

1 Feb 2005 20 Sep 2004 1 Nov 2015 1 Nov 2015 1 Jan 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Walter N. Kernan, M.D.